Top of page Skip navigation
One Nucleus: The Business Catalyst for Life Science Carolina Fernandes, Senior Funding & Innovation Manager, Newable

RowAnalytics: Complex Data Integration and Analytics Software

One Nucleus is an international membership organisation for life science and healthcare companies. They are based in Cambridge with the majority of our members across the Cambridge/London corridor – at the heart of Europe’s largest life science and healthcare cluster. Harriet Fear CEO for One Nucleus discusses with Adrian Dawkes of PharmaVentures a range of subjects concerning business practices within an uncertain environment. Newable: 'We believe confidence transforms business. RowAnalytics’ complex data integration and analytics software puts the power of real-time decision support and semantic search at your fingertips across mobile, smart, wearable and IoT devices
Ben Newton, General Manager PET and Director of Neurology, GE Healthcare Centauri Therapeutics: Focused on the discovery and development of novel molecules targeting life threatening diseases. BCF: A Different kind of practice
GE Healthcare (NYSE: GE) provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. The Alphamer technology is based on "programmable immunity" in which chemically synthesised molecules redirect naturally occurring antibodies to selected pathogens to fight the infection.  With more than 200 professionals working in 22 strategic multidisciplinary teams, BCF is the reference for everything connected to business law.
MedCity: Your front door to the life sciences sector of London & England's greater south east JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium Karus Therapeutics: Developing best-in-class medicines to treat cancer
MedCity is a collaboration between the Mayor of London and the capital’s three Academic Health Science Centres - Imperial College Academic Health Science Centre, King’s Health Partners, and UCL Partners. Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium Johnson & Johnson Innovation, JLINX will offer scientists and entrepreneurs access to venture funding, R&D expertise and state-of-the-art facilities JLINX is designed to accelerate early-stage transformative innovation, including an emphasis on the human microbiome as well as broader life-science research  Karus is a leader in the design and development of innovative cancer therapies; these small-molecule drugs combine targeted therapy with immunotherapeutic activity for the effective treatment of a diverse range of tumors.
Atlantic Healthcare: Addressing the clinical needs of GI patients    
Atlantic Healthcare plc is an emerging trans-Atlantic pharmaceutical group addressing the clinical needs of patients under specialist care, with an existing focus on gastrointestinal (GI) disease.